Cargando…
Valproic acid decreases urothelial cancer cell proliferation and induces thrombospondin-1 expression
BACKGROUND: Prevention of bladder cancer recurrence is a central challenge in the management of this highly prevalent disease. The histone deacetylase inhibitor valproic acid (sodium valproate) has anti-angiogenic properties and has been shown to decrease bladder cancer growth in model systems. We h...
Autores principales: | Byler, Timothy K, Leocadio, Dean, Shapiro, Oleg, Bratslavsky, Gennady, Stodgell, Christopher J, Wood, Ronald W, Messing, Edward M, Reeder, Jay E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487994/ https://www.ncbi.nlm.nih.gov/pubmed/22898175 http://dx.doi.org/10.1186/1471-2490-12-21 |
Ejemplares similares
-
Transrectal Ultrasound in Prostate Cancer: Current Utilization, Integration with mpMRI, HIFU and Other Emerging Applications
por: Panzone, John, et al.
Publicado: (2022) -
Applications of Focused Ultrasound in the Treatment of Genitourinary Cancers
por: Panzone, John, et al.
Publicado: (2022) -
An Unusual Etiology of Urinary Retention – Small Cell Prostate Carcinoma
por: Li, Guanqun, et al.
Publicado: (2016) -
Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1
por: Johnson, Aimee M, et al.
Publicado: (2008) -
Targeting Hsp90 in urothelial carcinoma
por: Chehab, Mahmoud, et al.
Publicado: (2015)